Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) EV/FCF
As of 16 October 2026, Solventum Corporation (SOLV) trades at a EV/FCF of −167×. Over the past ten years it has ranged from −1,925× (January 2026) to 371× (November 2025); the current reading is higher than 17% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | −1,805× | — |
| FY2024 | 23.2× | 176.96% |
| FY2023 | 8.4× | 0.00% |
| FY2022 | 8.4× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | −154× | — |
| Mar 2026 | −79.3× | — |
| Dec 2025 | −1,805× | — |
| Sep 2025 | 326× | 132.60% |
| 10 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SOLV Solventum Corporation | −167× |
| ALGN Align Technology, Inc. compare | 14.0× |
| COO The Cooper Companies, Inc. compare | 20.0× |
| ALC Alcon compare | 22.3× |
| BAX Baxter International Inc. compare | 25.0× |
| ATR AptarGroup, Inc. compare | 28.9× |
| AVTR Avantor, Inc. compare | 31.9× |
| WST West Pharmaceutical Services, Inc. compare | 62.1× |
| RGEN Repligen Corporation compare | 159× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement